Business Segments · Currency translation/Other
Innovative Medicine — Currency translation/Other
Johnson & Johnson Innovative Medicine — Currency translation/Other decreased by 371.9% to -$155.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 172.1%, from $215.00M to -$155.00M. Over 2 years (FY 2023 to FY 2025), Innovative Medicine — Currency translation/Other shows an upward trend with a 91.2% CAGR.
Analysis
StatementSegment
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026Apr 22, 2026
Rolls up toOther operating expenses
How to read this metric
Fluctuations reflect broader macroeconomic trends in currency markets rather than operational performance.
Detailed definition
Represents the net impact of foreign currency exchange rate fluctuations and other miscellaneous adjustments on the good...
Peer comparison
Standard 'Foreign Currency Translation' adjustment found in segment asset roll-forwards for global companies.
Metric ID:
jnj_segment_innovative_medicine_currency_translation_otherHistorical Data
18 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$79.00M | -$146.00M | -$170.00M | -$375.00M | -$375.00M | $124.00M | $13.00M | -$172.00M | $258.00M | -$145.00M | -$57.00M | $287.00M | -$440.00M | $215.00M | $543.00M | $0.00 | $57.00M | -$155.00M |
| QoQ Change | — | -84.8% | -16.4% | -120.6% | +0.0% | +133.1% | -89.5% | <-999% | +250.0% | -156.2% | +60.7% | +603.5% | -253.3% | +148.9% | +152.6% | -100.0% | — | -371.9% |
| YoY Change | — | — | — | — | -374.7% | +172.9% | +103.5% | +54.1% | — | -216.9% | -538.5% | +266.9% | -270.5% | +248.3% | >999% | -100.0% | +113.0% | -172.1% |
Range-$440.00M – $543.00M
CAGR+17.2%
Avg YoY Growth+26.0%
Median YoY Growth+54.1%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's innovative medicine — currency translation/other?
- Johnson & Johnson (JNJ) reported innovative medicine — currency translation/other of -$155.00M in Q1 2026.
- How has Johnson & Johnson's innovative medicine — currency translation/other changed year-over-year?
- Johnson & Johnson's innovative medicine — currency translation/other decreased by 172.1% year-over-year, from $215.00M to -$155.00M.
- What is the long-term trend for Johnson & Johnson's innovative medicine — currency translation/other?
- Over 2 years (2023 to 2025), Johnson & Johnson's innovative medicine — currency translation/other has grown at a 91.2% compound annual growth rate (CAGR), from $223.00M to $815.00M.
- What does innovative medicine — currency translation/other mean?
- Changes in the value of Innovative Medicine's goodwill due to currency exchange rates and other non-operational factors.